Hand Eczema clinical trials

Explore recruiting hand eczema clinical trials.

Recruiting hand eczema studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hand Eczema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AliCsa; Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospective open-label trial with blinded outcome assessment

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate-to-severe atopic hand eczema who are candidates for systemic therapy (ADHAND)

Sweden, France, Czechia, Germany, Portugal, Belgium +3 more

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of Chronic Hand Eczema with Oral Roflumilast (HERO) – a randomized controlled trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Abrocitinib in Subjects with Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Hand Eczema trials by city

Hand Eczema in Toronto Hand Eczema in Vancouver Hand Eczema in Montreal Hand Eczema in Calgary Hand Eczema in Edmonton Hand Eczema in Ottawa Hand Eczema in Winnipeg Hand Eczema in Quebec City Hand Eczema in Hamilton Hand Eczema in Kitchener Hand Eczema in London Hand Eczema in Halifax Hand Eczema in New York Hand Eczema in Los Angeles Hand Eczema in Chicago Hand Eczema in Houston

Hand Eczema clinical trials

Recruiting hand eczema studies right now

Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics

Also recruiting in Europe

AliCsa; Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospective open-label trial with blinded outcome assessment

A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate-to-severe atopic hand eczema who are candidates for systemic therapy (ADHAND)

A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema

Treatment of Chronic Hand Eczema with Oral Roflumilast (HERO) – a randomized controlled trial

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Abrocitinib in Subjects with Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Hand Eczema trials by city

Other conditions